These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 36703982)

  • 1. Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy.
    Ghasemi M; Abbasi L; Ghanbari Naeini L; Kokabian P; Nameh Goshay Fard N; Givtaj N
    Front Immunol; 2022; 13():950079. PubMed ID: 36703982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The two-faces of NK cells in oncolytic virotherapy.
    Marotel M; Hasim MS; Hagerman A; Ardolino M
    Cytokine Growth Factor Rev; 2020 Dec; 56():59-68. PubMed ID: 32586674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging field of oncolytic virus-based cancer immunotherapy.
    Ma R; Li Z; Chiocca EA; Caligiuri MA; Yu J
    Trends Cancer; 2023 Feb; 9(2):122-139. PubMed ID: 36402738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Killer Cells Recruitment in Oncolytic Virotherapy: A Mathematical Model.
    Senekal NS; Mahasa KJ; Eladdadi A; de Pillis L; Ouifki R
    Bull Math Biol; 2021 May; 83(7):75. PubMed ID: 34008149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy.
    Chowaniec H; Ślubowska A; Mroczek M; Borowczyk M; Braszka M; Dworacki G; Dobosz P; Wichtowski M
    Front Immunol; 2024; 15():1375433. PubMed ID: 38576614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic viruses and their application to cancer immunotherapy.
    Chiocca EA; Rabkin SD
    Cancer Immunol Res; 2014 Apr; 2(4):295-300. PubMed ID: 24764576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses.
    Jafari M; Kadkhodazadeh M; Shapourabadi MB; Goradel NH; Shokrgozar MA; Arashkia A; Abdoli S; Sharifzadeh Z
    Front Immunol; 2022; 13():1012806. PubMed ID: 36311790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia.
    Wang W; Liu S; Dai P; Yang N; Wang Y; Giese RA; Merghoub T; Wolchok J; Deng L
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy.
    Volovat SR; Scripcariu DV; Vasilache IA; Stolniceanu CR; Volovat C; Augustin IG; Volovat CC; Ostafe MR; Andreea-Voichița SG; Bejusca-Vieriu T; Lungulescu CV; Sur D; Boboc D
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment.
    Ghasemi Darestani N; Gilmanova AI; Al-Gazally ME; Zekiy AO; Ansari MJ; Zabibah RS; Jawad MA; Al-Shalah SAJ; Rizaev JA; Alnassar YS; Mohammed NM; Mustafa YF; Darvishi M; Akhavan-Sigari R
    Cell Commun Signal; 2023 Feb; 21(1):43. PubMed ID: 36829187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment.
    Feola S; Russo S; Ylösmäki E; Cerullo V
    Pharmacol Ther; 2022 Aug; 236():108103. PubMed ID: 34954301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic virotherapy in cancer treatment: challenges and optimization prospects.
    Chen L; Zuo M; Zhou Q; Wang Y
    Front Immunol; 2023; 14():1308890. PubMed ID: 38169820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and application of oncolytic viruses for cancer immunotherapy.
    Ylösmäki E; Cerullo V
    Curr Opin Biotechnol; 2020 Oct; 65():25-36. PubMed ID: 31874424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic virotherapy against lung cancer: key receptors and signaling pathways of viral entry.
    Dong W; Luo Y; He D; Zhang M; Zeng J; Chen Y
    Front Immunol; 2024; 15():1473288. PubMed ID: 39430750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.
    Wei D; Xu J; Liu XY; Chen ZN; Bian H
    Hum Gene Ther; 2018 Feb; 29(2):151-159. PubMed ID: 29284308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures.
    Schäfer TE; Knol LI; Haas FV; Hartley A; Pernickel SCS; Jády A; Finkbeiner MSC; Achberger J; Arelaki S; Modic Ž; Schröer K; Zhang W; Schmidt B; Schuster P; Haferkamp S; Doerner J; Gebauer F; Ackermann M; Kvasnicka HM; Kulkarni A; Bots STF; Kemp V; Hawinkels LJAC; Poetsch AR; Hoeben RC; Ehrhardt A; Marchini A; Ungerechts G; Ball CR; Engeland CE
    EBioMedicine; 2024 Jul; 105():105219. PubMed ID: 38941955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections.
    Wares JR; Crivelli JJ; Yun CO; Choi IK; Gevertz JL; Kim PS
    Math Biosci Eng; 2015 Dec; 12(6):1237-56. PubMed ID: 26775859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
    Sadri M; Najafi A; Rahimi A; Behranvand N; Hossein Kazemi M; Khorramdelazad H; Falak R
    Int Immunopharmacol; 2023 Sep; 122():110470. PubMed ID: 37433246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy.
    Kim Y; Clements DR; Sterea AM; Jang HW; Gujar SA; Lee PW
    Viruses; 2015 Dec; 7(12):6506-25. PubMed ID: 26690204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Virotherapy and the Tumor Microenvironment.
    Berkey SE; Thorne SH; Bartlett DL
    Adv Exp Med Biol; 2017; 1036():157-172. PubMed ID: 29275471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.